101 related articles for article (PubMed ID: 19293605)
1. Bone and bone turnover.
Crofton PM
Endocr Dev; 2009; 15():77-100. PubMed ID: 19293605
[TBL] [Abstract][Full Text] [Related]
2. Bone mineral density in survivors of childhood brain tumours.
Petraroli M; D'Alessio E; Ausili E; Barini A; Caradonna P; Riccardi R; Caldarelli M; Rossodivita A
Childs Nerv Syst; 2007 Jan; 23(1):59-65. PubMed ID: 17058089
[TBL] [Abstract][Full Text] [Related]
3. Reduced bone mineral density in young adults following cure of acute lymphoblastic leukaemia in childhood.
Brennan BM; Rahim A; Adams JA; Eden OB; Shalet SM
Br J Cancer; 1999 Apr; 79(11-12):1859-63. PubMed ID: 10206305
[TBL] [Abstract][Full Text] [Related]
4. [Accretion of bone mass in patients treated for childhood acute lymphoblastic leukemia].
Muszyńska-Rosłan K; Konstantynowicz J; Krawczuk-Rybak M
Pol Merkur Lekarski; 2007 Oct; 23(136):271-5. PubMed ID: 18293849
[TBL] [Abstract][Full Text] [Related]
5. Bone mineral density and serum bone turnover markers in survivors of childhood acute lymphoblastic leukemia: comparison of megadose methylprednisolone and conventional-dose prednisolone treatments.
Alikasifoglu A; Yetgin S; Cetin M; Tuncer M; Gumruk F; Gurgey A; Yordam N
Am J Hematol; 2005 Oct; 80(2):113-8. PubMed ID: 16184587
[TBL] [Abstract][Full Text] [Related]
6. Skeletal morbidity in childhood acute lymphoblastic leukemia.
Mandel K; Atkinson S; Barr RD; Pencharz P
J Clin Oncol; 2004 Apr; 22(7):1215-21. PubMed ID: 15051768
[TBL] [Abstract][Full Text] [Related]
7. Bone mineral density and bone turnover in young adult survivors of childhood acute lymphoblastic leukaemia.
Jarfelt M; Fors H; Lannering B; Bjarnason R
Eur J Endocrinol; 2006 Feb; 154(2):303-9. PubMed ID: 16452545
[TBL] [Abstract][Full Text] [Related]
8. Male sex and low physical activity are associated with reduced spine bone mineral density in survivors of childhood acute lymphoblastic leukemia.
Tillmann V; Darlington AS; Eiser C; Bishop NJ; Davies HA
J Bone Miner Res; 2002 Jun; 17(6):1073-80. PubMed ID: 12054163
[TBL] [Abstract][Full Text] [Related]
9. Effects of up to 15 years of recombinant human GH (rhGH) replacement on bone metabolism in adults with growth hormone deficiency (GHD): the Leiden Cohort Study.
Appelman-Dijkstra NM; Claessen KM; Hamdy NA; Pereira AM; Biermasz NR
Clin Endocrinol (Oxf); 2014 Nov; 81(5):727-35. PubMed ID: 24816144
[TBL] [Abstract][Full Text] [Related]
10. Improvement in bone mineral density and body composition in survivors of childhood acute lymphoblastic leukemia: a 1-year prospective study.
Marinovic D; Dorgeret S; Lescoeur B; Alberti C; Noel M; Czernichow P; Sebag G; Vilmer E; Léger J
Pediatrics; 2005 Jul; 116(1):e102-8. PubMed ID: 15995009
[TBL] [Abstract][Full Text] [Related]
11. Little evidence of low bone mass in acute lymphoblastic leukemia survivors.
Muszynska-Roslan K; Panasiuk A; Latoch E; Krawczuk-Rybak M; Konstantynowicz J
J Clin Densitom; 2012; 15(1):108-15. PubMed ID: 21880524
[TBL] [Abstract][Full Text] [Related]
12. Bone mineral density is compromised in very long-term survivors of irradiated childhood brain tumor.
Remes TM; Arikoski PM; Lähteenmäki PM; Arola MO; Pokka TM; Riikonen VP; Sirkiä KH; Rantala HMJ; Harila-Saari AH; Ojaniemi MK
Acta Oncol; 2018 May; 57(5):665-674. PubMed ID: 29374996
[TBL] [Abstract][Full Text] [Related]
13. No impact of disease and its treatment on bone mineral density in survivors of childhood acute lymphoblastic leukemia.
Jain S; Jain S; Kapoor G; Virmani A; Bajpai R
Pediatr Blood Cancer; 2017 Apr; 64(4):. PubMed ID: 27671543
[TBL] [Abstract][Full Text] [Related]
14. Bone mineral density in long-term survivors of childhood cancer.
Hesseling PB; Hough SF; Nel ED; van Riet FA; Beneke T; Wessels G
Int J Cancer Suppl; 1998; 11():44-7. PubMed ID: 9876477
[TBL] [Abstract][Full Text] [Related]
15. Risk factors and surveillance for reduced bone mineral density in pediatric cancer survivors.
Siegel DA; Claridy M; Mertens A; George E; Vangile K; Simoneaux SF; Meacham LR; Wasilewski-Masker K
Pediatr Blood Cancer; 2017 Sep; 64(9):. PubMed ID: 28233475
[TBL] [Abstract][Full Text] [Related]
16. Osteopenia in children who have undergone posterior fossa or craniospinal irradiation for brain tumors.
Krishnamoorthy P; Freeman C; Bernstein ML; Lawrence S; Rodd C
Arch Pediatr Adolesc Med; 2004 May; 158(5):491-6. PubMed ID: 15123484
[TBL] [Abstract][Full Text] [Related]
17. Randomized trial of effect of alendronate continuation versus discontinuation in women with low BMD: results from the Fracture Intervention Trial long-term extension.
Ensrud KE; Barrett-Connor EL; Schwartz A; Santora AC; Bauer DC; Suryawanshi S; Feldstein A; Haskell WL; Hochberg MC; Torner JC; Lombardi A; Black DM;
J Bone Miner Res; 2004 Aug; 19(8):1259-69. PubMed ID: 15231012
[TBL] [Abstract][Full Text] [Related]
18. Bone mineral density in survivors of childhood acute lymphoblastic leukemia.
Athanassiadou F; Tragiannidis A; Rousso I; Katsos G; Sidi V; Papageorgiou T; Papastergiou C; Tsituridis I; Koliouskas D
Turk J Pediatr; 2006; 48(2):101-4. PubMed ID: 16848106
[TBL] [Abstract][Full Text] [Related]
19. Effect of low-dose alendronate treatment on bone mineral density and bone turnover markers in Chinese postmenopausal women with osteopenia and osteoporosis.
Li M; Zhang ZL; Liao EY; Chen DC; Liu J; Tao TZ; Wu W; Xia WB; Lu YJ; Sheng ZF; Lu CY; Meng GL; Xu L; Zhang WJ; Hu YY; Xu L
Menopause; 2013 Jan; 20(1):72-8. PubMed ID: 22968256
[TBL] [Abstract][Full Text] [Related]
20. Recovery of bone mass and normalization of bone turnover in long-term survivors of allogeneic bone marrow transplantation.
Kananen K; Volin L; Tähtelä R; Laitinen K; Ruutu T; Välimäki MJ
Bone Marrow Transplant; 2002 Jan; 29(1):33-9. PubMed ID: 11840142
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
